Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 17;12(1):12.
doi: 10.1186/s40779-025-00599-y.

Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046

Affiliations

Global burden and cross-country inequalities in urinary tumors from 1990 to 2021 and predicted incidence changes to 2046

De-Chao Feng et al. Mil Med Res. .
No abstract available

Keywords: Disability-adjusted life-years (DALYs); Global burden of disease; Health inequality; Urinary tumors.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Global burden and cross-country inequalities in 4 urinary tumors from 1990 to 2021 and predicted incidence changes to 2046. Age and sex distribution of global DLAYs rate of BCa (a), KCa (b), PCa (c), and TCa (d) in 2021. Health inequality regression curves and concentration curves for the DALYs of BCa (e and f), KCa (g and h), PCa (i and j), and TCa (k and l) worldwide from 1990 to 2021. The global and China trends in ASR and case number of BCa (m), KCa (n), PCa (o), and TCa (p) between 1990 and 2021, and predicted changes to 2046. For Fig. 1 mp, the bar graph represents the case number of tumor patients and the line graph represents the ASR rate in global and China. BCa bladder cancer, KCa kidney cancer, PCa prostate cancer, TCa testicular cancer, ASR age-standardized rate, DALYs disability-adjusted life-years, SDI sociodemographic index

References

    1. Ren J, Song M, Zhang W, Cai JP, Cao F, Cao Z, et al. The aging biomarker consortium represents a new era for aging research in China. Nat Med. 2023;29(9):2162–5. - PubMed
    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. - PubMed
    1. Zi H, Liu MY, Luo LS, Huang Q, Luo PC, Luan HH, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64. - PMC - PubMed
    1. GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403(10440):2133–61. - PMC - PubMed
    1. Cao F, He YS, Wang Y, Zha CK, Lu JM, Tao LM, et al. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22(6):103326. - PubMed

LinkOut - more resources